Enrique Grande: How many challenges in GU tumors to try to address in the upcoming years?

Petros Grivas shared a post on X:

“Adding a few recent Grivas Selfie examples for friends Enrique Grande, Karima Oualla included Bernadett Szabados, Karine Tawagi and Amanda Nizam.

PS: bonus photo view from Barcelona added :-)”

Quoting Enrique Grande:

“What a lovely discussion Karima Oualla!!!!!

Thanks for visiting us at MD Anderson Madrid.

How many challenges in GU tumors to try to address in the upcoming years. Regarding the pictures, I don’t see the need to have Petros Grivas on it at all.”

Source: Petros Grivas/X

Dr. Petros Grivas, a board-certified medical oncologist, serves as Clinical Director of the Genitourinary Cancers Program at the University of Washington and Seattle Cancer Care Alliance. He’s an Associate Professor at the Dept. of Medicine and Associate Member at Fred Hutchinson Cancer Research Center since January 2018. With extensive training and experience, he’s led clinical trials, contributing to FDA approvals for bladder/urothelial cancer treatments.

Enrique Grande, MD, PhD, MSc, is an Associate Professor at Francisco de Vitoria University. He is also an Adjunct Professor at the GU Medical Oncology Department and the Head of Oncology at MD Anderson Cancer Center. Grande specializes in researching genitourinary and endocrine tumors and actively collaborates in developing the Translational Research and Early Drug Development Unit. He founded the Spanish Group for Research on Orphan and Uncommon Tumors (GETHI) and serves on the Directory Board of the Spanish Task Force Group for NETs (GETNE). Dr. Grande edits several international journals and has participated in recent neuroendocrine tumor trials that led to the approval of new drugs in this field.